Concentrix Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Concentrix han disminuido a una tasa media anual de -43.1%, mientras que en la industria Professional Services los beneficios crecieron en un 11.2% anualmente. Los ingresos han ido creciendo a una tasa media de 15.4% al año.
Información clave
-43.12%
Tasa de crecimiento de los beneficios
-43.65%
Tasa de crecimiento del BPA
| Crecimiento de la industria Professional Services | 10.99% |
| Tasa de crecimiento de los ingresos | 15.36% |
| Rentabilidad financiera | -47.61% |
| Margen neto | -13.36% |
| Última actualización de beneficios | 28 Feb 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Apr 25
CNXC: Margin Resilience And Buybacks Will Support Future Upside Potential
Analysts have trimmed their Concentrix price targets by $12 to $25, citing more conservative assumptions around future P/E multiples, while keeping fair value, discount rate, and margin expectations broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts appear to see the P/E reset as a way to align expectations more closely with current sentiment, which can reduce the risk of overpaying for near term execution.Actualización de narrativa • Apr 10
CNXC: Higher Margin Outlook And Buybacks Will Support Future Upside Potential
Narrative Update The updated analyst price target for Concentrix moves from approximately $48.60 to about $41.25. This reflects recent cuts from several firms as analysts point to more measured revenue growth assumptions, offset by slightly higher projected profit margins and a lower future P/E multiple.Actualización de narrativa • Mar 27
CNXC: Higher Margin Outlook And Buybacks Will Support Future Undervalued Entry
The analyst price target for Concentrix has shifted from $62.20 to $48.60. Analysts attribute this change to updated assumptions around slower revenue growth, a higher profit margin profile, and a lower future P/E multiple following recent target cuts from Barrington, Baird, and Canaccord.Seeking Alpha • Mar 25
Why I'm Not Buying Concentrix Even At Less Than 3x Earnings
Summary Concentrix trades at extremely low valuation multiples, but its deep value is tempered by significant debt concerns. Concentrix continues to post organic revenue growth, though guidance for FY'26 was modestly below consensus on both the top and bottom lines. GAAP profitability and cash flow are materially lower than non-GAAP figures. Debt service further constrains shareholder returns. Despite the apparent value, I assign a hold rating to CNXC due to looming debt maturities and potentially existential AI disruption risk. Read the full article on Seeking AlphaActualización de narrativa • Mar 12
CNXC: AI Rollout And Buybacks Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated views captured in recent research while keeping key fair value and growth assumptions essentially unchanged. Analyst Commentary Recent research around the $4 reduction in the price target highlights a mix of confidence in Concentrix’s core thesis and a more cautious stance on execution and risk.Actualización de narrativa • Feb 26
CNXC: Higher Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated assumptions around discount rates and valuation multiples, while keeping fair value estimates for the business broadly unchanged. Analyst Commentary Analysts describe the $4 price target cut as a fine tuning of their models rather than a reset of their overall view on Concentrix, with fair value estimates broadly intact.Artículo de análisis • Feb 16
Benign Growth For Concentrix Corporation (NASDAQ:CNXC) Underpins Stock's 30% Plummet
Concentrix Corporation ( NASDAQ:CNXC ) shareholders won't be pleased to see that the share price has had a very rough...Actualización de narrativa • Feb 12
CNXC: Updated Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have lowered their price target on Concentrix by $4, citing updated assumptions around discount rates and profitability, while keeping fair value estimates broadly stable. Analyst Commentary Analysts describe the recent US$4 reduction in the price target as a fine tuning of their view, reflecting updated discount rate assumptions and a more cautious stance on profitability, rather than a fundamental reset of Concentrix's underlying worth.Actualización de narrativa • Jan 29
CNXC: Updated Discount Rate And P/E Assumptions Will Support Future Undervalued Entry
Narrative Update on Concentrix Analysts have trimmed their price target on Concentrix by $4, citing updated assumptions around discount rates and future P/E expectations, while keeping their fair value estimate unchanged at $62.20. Analyst Commentary Recent research around Concentrix reflects a mixed tone, with the $4 trim to the price target tied mainly to updated discount rate inputs and revised P/E assumptions rather than a reset of the underlying fair value, which remains at $62.20.Actualización de narrativa • Jan 15
CNXC: Higher Discount Rate Reset Will Support Future Undervalued Entry Thesis
Analysts have trimmed their price target on Concentrix by about $2.63, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent research that included a $4 reduction highlighted at Baird. Analyst Commentary Analysts framing the new price target are trying to line up their fair value work with updated assumptions on discount rates, revenue growth, margins and the future P/E they think the market is willing to pay for Concentrix.Artículo de análisis • Nov 08
Concentrix Corporation (NASDAQ:CNXC) Not Doing Enough For Some Investors As Its Shares Slump 28%
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...Artículo de análisis • Sep 29
Concentrix's (NASDAQ:CNXC) Upcoming Dividend Will Be Larger Than Last Year's
The board of Concentrix Corporation ( NASDAQ:CNXC ) has announced that it will be paying its dividend of $0.36 on the...Actualización de narrativa • Sep 27
AI Integration And Webhelp Synergies Will Transform Business
Concentrix's consensus price target was modestly reduced to $64.83 as analysts factor in compressed valuation multiples from AI-related investor uncertainty and secular headwinds—rather than fundamental weakness—while maintaining confidence in growth reacceleration and strong business fundamentals. Analyst Commentary Compressed valuation multiples attributed to investor uncertainty over the impact of artificial intelligence on labor-intensive business models and broader secular headwinds, not due to fundamental company weakness.Artículo de análisis • Apr 03
Concentrix Corporation's (NASDAQ:CNXC) Shares Leap 26% Yet They're Still Not Telling The Full Story
The Concentrix Corporation ( NASDAQ:CNXC ) share price has done very well over the last month, posting an excellent...Artículo de análisis • Jan 29
The Market Lifts Concentrix Corporation (NASDAQ:CNXC) Shares 25% But It Can Do More
Concentrix Corporation ( NASDAQ:CNXC ) shareholders have had their patience rewarded with a 25% share price jump in the...Seeking Alpha • Jan 17
Concentrix: Better Than Expected Results, GenAI, And Cheap
Summary Concentrix Corporation delivered better-than-expected EPS and revenue, driven by significant investments in its GenAI product suite and a booming AI customer experience market. The AI in customer experience market is projected to grow at a 22% CAGR, potentially boosting CNXC's future revenue and free cash flow growth. Despite risks from high debt levels and potential global tariffs, CNXC's substantial headcount growth and consistent net income make it appear undervalued. My financial model suggests CNXC is significantly undervalued, with an equity valuation of $6.5 billion and a target price of $102 per share. Read the full article on Seeking AlphaSeeking Alpha • Dec 21
AI: Will Freshworks Leave Room For Concentrix?
Summary A.I. is revolutionising Customer Relationship Management (CRM), with Salesforce leading the market, leveraging Big Data to enhance customer interactions and sales conversions. Generative A.I. significantly boosts Customer Experience (CX) performance, with early adopters seeing a 25% increase in CX satisfaction, and the global CX market projected to grow to $33bn by 2030. Concentrix, with a $2.86bn market cap, offers comprehensive CX services including call centres. Freshworks is a SAAS only CX provider. Both companies have seen 70% plus share price declines, but one is still priced for growth, the other for business declines. Is this justified? Read the full article on Seeking AlphaSeeking Alpha • Nov 01
Concentrix: Significant Business Growth Driven By AI, And Cheap Valuation
Summary Concentrix's diversified client base, strong cash flow, and expanding AI-driven services make it a compelling buy at the current stock price. The company’s global presence and technological innovations in data analytics and AI are expected to drive future revenue and profitability growth. Concentrix's efficient debt management and significant undervaluation compared to peers suggest substantial upside potential. Despite potential risks from technological failures and client concentration, the company looks like a buy. Read the full article on Seeking AlphaArtículo de análisis • Oct 22
Positive Sentiment Still Eludes Concentrix Corporation (NASDAQ:CNXC) Following 26% Share Price Slump
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...
Nueva narrativa • Sep 26
Generative AI And Decisive Shifts Poise Company For Future Profitability Surge
Concentrix's investment in generative AI and focus on transformational deals are poised to enhance productivity, future revenue, and margins through differentiated services.Seeking Alpha • Sep 19
Concentrix: Hardly Growing Post-Merger (Rating Downgrade)
Summary Concentrix's Q3 report is due next week; past performance shows no growth and decreased efficiency, leading to a 30% stock decline. Revenue growth mainly from WebHelp merger; organic growth flat, with margins impacted by increased R&D spending, affecting ROA and ROE negatively. The company’s financial health is concerning with high debt and low interest coverage ratio, necessitating a conservative valuation approach. Downgrading to a hold rating; awaiting proof of improved growth and profitability from AI and merger before recommending a buy again. Read the full article on Seeking AlphaArtículo de análisis • Aug 21
Concentrix Corporation (NASDAQ:CNXC) Might Not Be As Mispriced As It Looks
With a median price-to-earnings (or "P/E") ratio of close to 18x in the United States, you could be forgiven for...Seeking Alpha • Jun 04
Concentrix: Worth A Look
Summary Concentrix Corporation's stock has declined by 40% since becoming an independent public entity. The merger with Webhelp will boost Concentrix's competitive profile and increase its exposure to the EMEA region. Despite its strong forward earnings growth profile (triple-digit growth in FY24, followed by double-digit growth through FY26), CNXC can be picked up at a forward P/E of less than 5x. Despite an adverse Q1, mainly due to one-off and seasonal issues, FCF generation will pick up meaningfully over the next 3 quarters and help the company deleverage to 2.5x net leverage. The charts are showing signs of bottoming out, and could receive additional support from an expected ramp-up in the buyback run rate. Read the full article on Seeking AlphaDesglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Concentrix. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 28 Feb 26 | 9,954 | -1,329 | 2,424 | 0 |
| 30 Nov 25 | 9,826 | -1,283 | 2,395 | 0 |
| 31 Aug 25 | 9,721 | 302 | 2,278 | 0 |
| 31 May 25 | 9,625 | 234 | 2,257 | 0 |
| 28 Feb 25 | 9,588 | 258 | 2,284 | 0 |
| 30 Nov 24 | 9,619 | 242 | 2,401 | 0 |
| 31 Aug 24 | 9,402 | 198 | 2,076 | 0 |
| 31 May 24 | 8,647 | 258 | 1,930 | 0 |
| 29 Feb 24 | 7,881 | 272 | 1,895 | 0 |
| 30 Nov 23 | 7,115 | 308 | 1,706 | 0 |
| 31 Aug 23 | 6,525 | 343 | 1,479 | 0 |
| 31 May 23 | 6,471 | 372 | 1,460 | 0 |
| 28 Feb 23 | 6,425 | 406 | 1,451 | 0 |
| 30 Nov 22 | 6,324 | 428 | 1,423 | 0 |
| 31 Aug 22 | 6,150 | 448 | 1,425 | 0 |
| 31 May 22 | 5,968 | 451 | 1,362 | 0 |
| 28 Feb 22 | 5,770 | 421 | 1,313 | 0 |
| 30 Nov 21 | 5,587 | 400 | 1,415 | 0 |
| 31 Aug 21 | 5,421 | 342 | 1,209 | 0 |
| 31 May 21 | 5,188 | 279 | 1,211 | 0 |
| 28 Feb 21 | 4,884 | 200 | 1,176 | 0 |
| 30 Nov 20 | 4,720 | 165 | 1,359 | 0 |
| 31 Aug 20 | 4,632 | 132 | 1,163 | 0 |
| 31 May 20 | 4,629 | 117 | 1,179 | 0 |
| 29 Feb 20 | 4,723 | 136 | 1,215 | 0 |
| 30 Nov 19 | 4,708 | 117 | 1,458 | 0 |
| 30 Nov 18 | 2,463 | 48 | 681 | 0 |
| 30 Nov 17 | 1,990 | 72 | 569 | 0 |
Ingresos de calidad: CNXC actualmente no es rentable.
Margen de beneficios creciente: CNXC actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: CNXC no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 43.1% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de CNXC en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: CNXC no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Professional Services (7.8%).
Rentabilidad financiera
Alta ROE: CNXC tiene una rentabilidad financiera negativa (-47.61%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/13 14:27 |
| Precio de las acciones al final del día | 2026/05/13 00:00 |
| Beneficios | 2026/02/28 |
| Ingresos anuales | 2025/11/30 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Concentrix Corporation está cubierta por 5 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| David Koning | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Ruplu Bhattacharya | BofA Global Research |